Therapeutic Approaches to Type I Interferonopathies

Purpose of Review To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Summary Type I interferonopathies represent a genetically and phenotypically heterogenous group of disorders of the innate immune system caused by constitutive activ...

Full description

Saved in:
Bibliographic Details
Published inCurrent rheumatology reports Vol. 20; no. 6; p. 32
Main Authors Bienias, Marc, Brück, Normi, Griep, Constanze, Wolf, Christine, Kretschmer, Stefanie, Kind, Barbara, Tüngler, Victoria, Berner, Reinhard, Lee-Kirsch, Min Ae
Format Journal Article
LanguageEnglish
Published New York Springer US 01.06.2018
Subjects
Online AccessGet full text
ISSN1523-3774
1534-6307
1534-6307
DOI10.1007/s11926-018-0743-3

Cover

Abstract Purpose of Review To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Summary Type I interferonopathies represent a genetically and phenotypically heterogenous group of disorders of the innate immune system caused by constitutive activation of antiviral type I interferon (IFN). Clinically, type I interferonopathies are characterized by autoinflammation and varying degrees of autoimmunity or immunodeficiency. The elucidation of the underlying genetic causes has revealed novel cell-intrinsic mechanisms that protect the organism against inappropriate immune recognition of self nucleic acids by cytosolic nucleic acid sensors. The type I IFN system is subject to a tight and complex regulation. Disturbances of its checks and balances can spark an unwanted immune response causing uncontrolled type I IFN signaling. Novel mechanistic insight into pathways that control the type I IFN system is providing opportunities for targeted therapeutic approaches by repurposing drugs such as Janus kinase inhibitors or reverse transcriptase inhibitors.
AbstractList To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Type I interferonopathies represent a genetically and phenotypically heterogenous group of disorders of the innate immune system caused by constitutive activation of antiviral type I interferon (IFN). Clinically, type I interferonopathies are characterized by autoinflammation and varying degrees of autoimmunity or immunodeficiency. The elucidation of the underlying genetic causes has revealed novel cell-intrinsic mechanisms that protect the organism against inappropriate immune recognition of self nucleic acids by cytosolic nucleic acid sensors. The type I IFN system is subject to a tight and complex regulation. Disturbances of its checks and balances can spark an unwanted immune response causing uncontrolled type I IFN signaling. Novel mechanistic insight into pathways that control the type I IFN system is providing opportunities for targeted therapeutic approaches by repurposing drugs such as Janus kinase inhibitors or reverse transcriptase inhibitors.PURPOSE OF REVIEWTo review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Type I interferonopathies represent a genetically and phenotypically heterogenous group of disorders of the innate immune system caused by constitutive activation of antiviral type I interferon (IFN). Clinically, type I interferonopathies are characterized by autoinflammation and varying degrees of autoimmunity or immunodeficiency. The elucidation of the underlying genetic causes has revealed novel cell-intrinsic mechanisms that protect the organism against inappropriate immune recognition of self nucleic acids by cytosolic nucleic acid sensors. The type I IFN system is subject to a tight and complex regulation. Disturbances of its checks and balances can spark an unwanted immune response causing uncontrolled type I IFN signaling. Novel mechanistic insight into pathways that control the type I IFN system is providing opportunities for targeted therapeutic approaches by repurposing drugs such as Janus kinase inhibitors or reverse transcriptase inhibitors.
To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Type I interferonopathies represent a genetically and phenotypically heterogenous group of disorders of the innate immune system caused by constitutive activation of antiviral type I interferon (IFN). Clinically, type I interferonopathies are characterized by autoinflammation and varying degrees of autoimmunity or immunodeficiency. The elucidation of the underlying genetic causes has revealed novel cell-intrinsic mechanisms that protect the organism against inappropriate immune recognition of self nucleic acids by cytosolic nucleic acid sensors. The type I IFN system is subject to a tight and complex regulation. Disturbances of its checks and balances can spark an unwanted immune response causing uncontrolled type I IFN signaling. Novel mechanistic insight into pathways that control the type I IFN system is providing opportunities for targeted therapeutic approaches by repurposing drugs such as Janus kinase inhibitors or reverse transcriptase inhibitors.
Purpose of Review To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Summary Type I interferonopathies represent a genetically and phenotypically heterogenous group of disorders of the innate immune system caused by constitutive activation of antiviral type I interferon (IFN). Clinically, type I interferonopathies are characterized by autoinflammation and varying degrees of autoimmunity or immunodeficiency. The elucidation of the underlying genetic causes has revealed novel cell-intrinsic mechanisms that protect the organism against inappropriate immune recognition of self nucleic acids by cytosolic nucleic acid sensors. The type I IFN system is subject to a tight and complex regulation. Disturbances of its checks and balances can spark an unwanted immune response causing uncontrolled type I IFN signaling. Novel mechanistic insight into pathways that control the type I IFN system is providing opportunities for targeted therapeutic approaches by repurposing drugs such as Janus kinase inhibitors or reverse transcriptase inhibitors.
ArticleNumber 32
Author Griep, Constanze
Lee-Kirsch, Min Ae
Brück, Normi
Wolf, Christine
Tüngler, Victoria
Kind, Barbara
Berner, Reinhard
Bienias, Marc
Kretschmer, Stefanie
Author_xml – sequence: 1
  givenname: Marc
  surname: Bienias
  fullname: Bienias, Marc
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 2
  givenname: Normi
  surname: Brück
  fullname: Brück, Normi
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 3
  givenname: Constanze
  surname: Griep
  fullname: Griep, Constanze
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 4
  givenname: Christine
  surname: Wolf
  fullname: Wolf, Christine
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 5
  givenname: Stefanie
  surname: Kretschmer
  fullname: Kretschmer, Stefanie
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 6
  givenname: Barbara
  surname: Kind
  fullname: Kind, Barbara
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 7
  givenname: Victoria
  surname: Tüngler
  fullname: Tüngler, Victoria
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 8
  givenname: Reinhard
  surname: Berner
  fullname: Berner, Reinhard
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
– sequence: 9
  givenname: Min Ae
  surname: Lee-Kirsch
  fullname: Lee-Kirsch, Min Ae
  email: minae.lee-kirsch@uniklinikum-dresden.de
  organization: Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29679241$$D View this record in MEDLINE/PubMed
BookMark eNp9kD1PwzAQQC1URFvgB7CgjCwBn-3EyVhVfFRCYimz5dgXGtTGwXaG_ntclS4MnWxZ753Ob04mveuRkDugj0CpfAoANStzClVOpeA5vyAzKLjIS07l5HBn6VFKMSXzEL4pZZRW_IpMWV3KmgmYEb7eoNcDjrEz2WIYvNNmgyGLLlvvB8xW2aqP6Fv0rneDjpsOww25bPU24O3feU0-X57Xy7f8_eN1tVy854YLEfOmLhtrrZaMYWtLBCaLusIaDGvSlhZMBQ3KorVWaMN0UUkLYFsjgBdUCH5NHo5z01Y_I4aodl0wuN3qHt0YFKOsqosaOEvo_R86Nju0avDdTvu9On00AfIIGO9C8Ngq00UdO9dHr7utAqoOSdUxqUpJ1SGp4smEf-Zp-DmHHZ2Q2P4Lvfp2o-9TrDPSL-zHhz0
CitedBy_id crossref_primary_10_1016_j_braindev_2020_10_005
crossref_primary_10_1080_1744666X_2019_1707663
crossref_primary_10_1111_sji_13314
crossref_primary_10_3390_ijms20071620
crossref_primary_10_3390_molecules26123602
crossref_primary_10_1186_s40348_023_00161_7
crossref_primary_10_3390_cells11142231
crossref_primary_10_3389_fped_2021_631329
crossref_primary_10_3390_jpm13111609
crossref_primary_10_1038_s41423_020_00626_z
crossref_primary_10_47184_ti_2021_03_04
crossref_primary_10_3390_ijms22126360
crossref_primary_10_1007_s10067_023_06645_1
crossref_primary_10_1007_s11926_019_0854_5
crossref_primary_10_1093_rheumatology_keaa657
crossref_primary_10_1007_s00112_022_01436_5
crossref_primary_10_1055_a_2352_7224
crossref_primary_10_1186_s12969_022_00686_7
Cites_doi 10.1038/nri3581
10.1056/NEJMoa1312625
10.1146/annurev-med-051113-024537
10.1186/1742-4690-8-91
10.1146/annurev-med-050715-104506
10.1038/ni.2236
10.1038/nri.2016.78
10.1136/annrheumdis-2016-210715
10.1172/JCI81260
10.1086/513443
10.1016/j.stem.2017.07.009
10.1016/j.jaci.2016.10.030
10.1016/j.cell.2017.12.016
10.1038/ni.3777
10.1074/jbc.M112.431148
10.1002/ajmg.a.33778
10.1002/art.40122
10.1038/s41467-017-01932-3
10.1177/0883073811408310
10.1007/s00109-007-0199-9
10.1016/j.tim.2015.08.002
10.4049/jimmunol.1600722
10.1002/ajmg.a.36887
10.1111/j.1749-6632.2011.06220.x
10.4049/jimmunol.1400737
10.1172/JCI78001
10.1038/ng.2933
10.4049/jimmunol.1700714
10.1002/art.39962
10.1038/nri.2016.27
10.1136/annrheumdis-2015-208562
10.1136/annrheumdis-2016-210565
10.1016/S1474-4422(13)70258-8
10.1016/j.jaci.2016.07.015
10.1038/ncomms11752
10.1038/ng1845
10.1172/JCI79100
10.1038/ni.1941
10.1038/ng1842
10.1016/j.ajhg.2010.10.031
10.1097/MOH.0000000000000320
10.1038/nm.3626
10.1038/ng.373
10.1002/art.33368
10.1016/j.cell.2012.04.011
10.1016/j.molcel.2012.06.035
10.1016/j.cell.2007.10.017
10.1016/j.cell.2008.06.032
10.1038/nature10623
10.1086/507848
10.1038/ng.2414
10.2217/imt-2017-0156
10.1038/ng2091
10.1007/s00109-013-0995-3
10.1084/jem.20120876
10.1126/science.aac7049
10.15252/embj.201593339
10.1182/blood-2013-04-490847
10.1038/gene.2010.73
10.1093/hmg/ddu319
10.4049/jimmunol.1500969
10.1136/annrheumdis-2014-205396
10.1002/ana.410150109
10.1084/jem.20151464
10.1002/art.27367
10.1136/annrheumdis-2016-209841
10.1136/annrheumdis-2013-204845
10.1002/cpt.936
10.1172/JCI98814
10.1002/art.39810
ContentType Journal Article
Copyright Springer Science+Business Media, LLC, part of Springer Nature 2018
Copyright_xml – notice: Springer Science+Business Media, LLC, part of Springer Nature 2018
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1007/s11926-018-0743-3
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1534-6307
ExternalDocumentID 29679241
10_1007_s11926_018_0743_3
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Deutsche Forschungsgemeinschaft
  grantid: Clinical Research Unit 249; LE 1074/4-2 to M.L.-K and TU 421/1-2 to V.T.
  funderid: http://dx.doi.org/10.13039/501100001659
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29F
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEGXH
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
BSONS
C1A
CAG
COF
CS3
CSCUP
CUW
DDRTE
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
I~Z
J-C
JBSCW
JZLTJ
KOV
LLZTM
M4Y
MA-
N9A
NPVJJ
NQJWS
NU0
O9-
O9J
P9S
PF0
PT4
PT5
QOR
QOS
R89
R9I
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z7U
Z81
Z82
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
NPM
7X8
ID FETCH-LOGICAL-c344t-b96bddda722efd6e127598e91c2b153d1c81be75fdd4ac2a587d11dfc41350443
IEDL.DBID AGYKE
ISSN 1523-3774
1534-6307
IngestDate Fri Sep 05 02:54:33 EDT 2025
Mon Jul 21 05:59:17 EDT 2025
Thu Apr 24 22:56:29 EDT 2025
Wed Oct 01 01:13:10 EDT 2025
Fri Feb 21 02:45:22 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Autoinflammation
ᅟType I interferonopathies
Therapy
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-b96bddda722efd6e127598e91c2b153d1c81be75fdd4ac2a587d11dfc41350443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 29679241
PQID 2028959132
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2028959132
pubmed_primary_29679241
crossref_citationtrail_10_1007_s11926_018_0743_3
crossref_primary_10_1007_s11926_018_0743_3
springer_journals_10_1007_s11926_018_0743_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-06-01
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Current rheumatology reports
PublicationTitleAbbrev Curr Rheumatol Rep
PublicationTitleAlternate Curr Rheumatol Rep
PublicationYear 2018
Publisher Springer US
Publisher_xml – name: Springer US
References Ramantani, Hausler, Niggemann, Wessling, Guttmann, Mull (CR10) 2011; 26
Seo, Kang, Suh, Park, Lee, Choi, Kim, Kim, Park, Ye, Kwon, Park, Lim, Lee, Kang, Choi, Park, Chae (CR53) 2017; 139
Lee-Kirsch, Gong, Chowdhury, Senenko, Engel, Lee, de Silva, Bailey, Witte, Vyse, Kere, Pfeiffer, Harvey, Wong, Koskenmies, Hummel, Rohde, Schmidt, Dominiczak, Gahr, Hollis, Perrino, Lieberman, Hübner (CR65) 2007; 39
Cuadrado, Vanderver, Brown, Sandza, Takanohashi, Jansen, Anink, Herron, Orcesi, Olivieri, Rice, Aronica, Lebon, Crow, Hol, Kuijpers (CR11) 2014; 74
Pokatayev, Hasin, Chon, Cerritelli, Sakhuja, Ward, Morris, Yan, Crouch (CR29) 2016; 213
Ravenscroft, Suri, Rice, Szynkiewicz, Crow (CR41) 2011; 155A
Agarwal, Xing, DeMartino, Mizrachi, Hernandez, Sousa (CR45) 2010; 87
Gunther, Kind, Reijns, Berndt, Martinez-Bueno, Wolf (CR27) 2015; 125
Lee-Kirsch, Chowdhury, Harvey, Gong, Senenko, Engel, Pfeiffer, Hollis, Gahr, Perrino, Lieberman, Hubner (CR40) 2007; 85
Crow, Chase, Lowenstein Schmidt, Szynkiewicz, Forte, Gornall, Oojageer, Anderson, Pizzino, Helman, Abdel-Hamid, Abdel-Salam, Ackroyd, Aeby, Agosta, Albin, Allon-Shalev, Arellano, Ariaudo, Aswani, Babul-Hirji, Baildam, Bahi-Buisson, Bailey, Barnerias, Barth, Battini, Beresford, Bernard, Bianchi, Billette de Villemeur, Blair, Bloom, Burlina, Carpanelli, Carvalho, Castro-Gago, Cavallini, Cereda, Chandler, Chitayat, Collins, Sierra Corcoles, Cordeiro, Crichiutti, Dabydeen, Dale, D’Arrigo, de Goede, de Laet, de Waele, Denzler, Desguerre, Devriendt, di Rocco, Fahey, Fazzi, Ferrie, Figueiredo, Gener, Goizet, Gowrinathan, Gowrishankar, Hanrahan, Isidor, Kara, Khan, King, Kirk, Kumar, Lagae, Landrieu, Lauffer, Laugel, la Piana, Lim, Lin, Linnankivi, Mackay, Marom, Marques Lourenço, McKee, Moroni, Morton, Moutard, Murray, Nabbout, Nampoothiri, Nunez-Enamorado, Oades, Olivieri, Ostergaard, Pérez-Dueñas, Prendiville, Ramesh, Rasmussen, Régal, Ricci, Rio, Rodriguez, Roubertie, Salvatici, Segers, Sinha, Soler, Spiegel, Stödberg, Straussberg, Swoboda, Suri, Tacke, Tan, te Water Naude, Wee Teik, Thomas, Till, Tonduti, Valente, van Coster, van der Knaap, Vassallo, Vijzelaar, Vogt, Wallace, Wassmer, Webb, Whitehouse, Whitney, Zaki, Zuberi, Livingston, Rozenberg, Lebon, Vanderver, Orcesi, Rice (CR8) 2015; 167A
CR35
Liu, Ramot, Torrelo, Paller, Si, Babay, Kim, Sheikh, Lee, Chen, Vera, Zhang, Goldbach-Mansky, Zlotogorski (CR46) 2012; 64
Wolf, Rapp, Berndt, Staroske, Schuster, Dobrick-Mattheuer, Kretschmer, König, Kurth, Wieczorek, Kast, Cardoso, Günther, Lee-Kirsch (CR19) 2016; 7
Ivashkiv, Donlin (CR3) 2014; 14
Aicardi, Goutieres (CR7) 1984; 15
Gray, Treuting, Woodward, Stetson (CR22) 2015; 195
Ryoo, Choi, Oh, Kim, Seo, Kim, Seo, Kim, White, Brandariz-Nuñez, Diaz-Griffero, Yun, Hollenbaugh, Kim, Baek, Ahn (CR34) 2014; 20
Rice, Del Toro, Jenkinson, Forte, Anderson, Ariaudo (CR17) 2014; 46
Clifford, Louis, Robbe, Ackroyd, Burns, Timbs, Wright Colopy, Dreau, Sigaux, Judde, Rotger, Telenti, Lin, Pasero, Maelfait, Titsias, Cohen, Henderson, Ross, Bentley, Hillmen, Pettitt, Rehwinkel, Knight, Taylor, Crow, Benkirane, Schuh (CR36) 2014; 123
Furie, Khamashta, Merrill, Werth, Kalunian, Brohawn, Illei, Drappa, Wang, Yoo (CR69) 2017; 69
Crow, Hayward, Parmar, Robins, Leitch, Ali, Black, van Bokhoven, Brunner, Hamel, Corry, Cowan, Frints, Klepper, Livingston, Lynch, Massey, Meritet, Michaud, Ponsot, Voit, Lebon, Bonthron, Jackson, Barnes, Lindahl (CR13) 2006; 38
Tüngler, König, Günther, Engel, Fiehn, Smitka, von der Hagen, Berner, Lee-Kirsch (CR54) 2016; 75
Jagasia, Zeiser, Arbushites, Delaite, Gadbaw, von Bubnoff (CR50) 2018; 10
O’Shea, Schwartz, Villarino, Gadina, McInnes, Laurence (CR48) 2015; 66
Ramantani, Kohlhase, Hertzberg, Innes, Engel, Hunger, Borozdin, Mah, Ungerath, Walkenhorst, Richardt, Buckard, Bevot, Siegel, von Stülpnagel, Ikonomidou, Thomas, Proud, Niemann, Wieczorek, Häusler, Niggemann, Baltaci, Conrad, Lebon, Lee-Kirsch (CR9) 2010; 62
Yan, Regalado-Magdos, Stiggelbout, Lee-Kirsch, Lieberman (CR57) 2010; 11
Ablasser, Hemmerling, Schmid-Burgk, Behrendt, Roers, Hornung (CR21) 2014; 192
Thomas, Tejwani, Trujillo, Negraes, Herai, Mesci, Macia, Crow, Muotri (CR60) 2017; 21
Sparks, Chon, Cerritelli, Kunkel, Johansson, Crouch, Burgers (CR25) 2012; 47
Ballana, Esté (CR61) 2015; 23
Lee-Kirsch (CR5) 2017; 68
CR42
Liu, Jesus, Marrero, Yang, Ramsey, Montealegre Sanchez, Tenbrock, Wittkowski, Jones, Kuehn, Lee, DiMattia, Cowen, Gonzalez, Palmer, DiGiovanna, Biancotto, Kim, Tsai, Trier, Huang, Stone, Hill, Kim, St. Hilaire, Gurprasad, Plass, Chapelle, Horkayne-Szakaly, Foell, Barysenka, Candotti, Holland, Hughes, Mehmet, Issekutz, Raffeld, McElwee, Fontana, Minniti, Moir, Kastner, Gadina, Steven, Wingfield, Brooks, Rosenzweig, Fleisher, Deng, Boehm, Paller, Goldbach-Mansky (CR43) 2014; 371
Smolen, Landewé, Bijlsma, Burmester, Chatzidionysiou, Dougados, Nam, Ramiro, Voshaar, van Vollenhoven, Aletaha, Aringer, Boers, Buckley, Buttgereit, Bykerk, Cardiel, Combe, Cutolo, van Eijk-Hustings, Emery, Finckh, Gabay, Gomez-Reino, Gossec, Gottenberg, Hazes, Huizinga, Jani, Karateev, Kouloumas, Kvien, Li, Mariette, McInnes, Mysler, Nash, Pavelka, Poór, Richez, van Riel, Rubbert-Roth, Saag, da Silva, Stamm, Takeuchi, Westhovens, de Wit, van der Heijde (CR51) 2017; 76
Kind, Muster, Staroske, Herce, Sachse, Rapp, Schmidt, Koss, Cardoso, Lee-Kirsch (CR26) 2014; 23
Rodero, Tesser, Bartok, Rice, Della Mina, Depp, Beitz, Bondet, Cagnard, Duffy, Dussiot, Frémond, Gattorno, Guillem, Kitabayashi, Porcheray, Rieux-Laucat, Seabra, Uggenti, Volpi, Zeef, Alyanakian, Beltrand, Bianco, Boddaert, Brouzes, Candon, Caorsi, Charbit, Fabre, Faletra, Girard, Harroche, Hartmann, Lasne, Marcuzzi, Neven, Nitschke, Pascreau, Pastore, Picard, Picco, Piscianz, Polak, Quartier, Rabant, Stocco, Taddio, Uettwiller, Valencic, Vozzi, Hartmann, Barchet, Hermine, Bader-Meunier, Tommasini, Crow (CR6) 2017; 8
Ahmad, Mu, Yang, Greenwald, Park, Jacob, Zhang, Hur (CR62) 2018; 172
Liddicoat, Piskol, Chalk, Ramaswami, Higuchi, Hartner, Li, Seeburg, Walkley (CR37) 2015; 349
Frémond, Uggenti, Van Eyck, Melki, Bondet, Kitabayashi (CR70) 2017; 69
Tungler, Staroske, Kind, Dobrick, Kretschmer, Schmidt (CR32) 2013; 91
Crow (CR4) 2011; 1238
Lee-Kirsch, Gong, Schulz, Ruschendorf, Stein, Pfeiffer (CR38) 2006; 79
Jeremiah, Neven, Gentili, Callebaut, Maschalidi, Stolzenberg, Goudin, Frémond, Nitschke, Molina, Blanche, Picard, Rice, Crow, Manel, Fischer, Bader-Meunier, Rieux-Laucat (CR44) 2014; 124
CR56
Khamashta, Merrill, Werth, Furie, Kalunian, Illei, Drappa, Wang, Greth (CR68) 2016; 75
Yang, Lindahl, Barnes (CR18) 2007; 131
CR55
Peschke, Achleitner, Frenzel, Gerbaulet, Ada, Zeller (CR71) 2016; 197
Beloglazova, Flick, Tchigvintsev, Brown, Popovic, Nocek, Yakunin (CR33) 2013; 288
Rice, Bond, Asipu, Brunette, Manfield, Carr, Fuller, Jackson, Lamb, Briggs, Ali, Gornall, Couthard, Aeby, Attard-Montalto, Bertini, Bodemer, Brockmann, Brueton, Corry, Desguerre, Fazzi, Cazorla, Gener, Hamel, Heiberg, Hunter, van der Knaap, Kumar, Lagae, Landrieu, Lourenco, Marom, McDermott, van der Merwe, Orcesi, Prendiville, Rasmussen, Shalev, Soler, Shinawi, Spiegel, Tan, Vanderver, Wakeling, Wassmer, Whittaker, Lebon, Stetson, Bonthron, Crow (CR15) 2009; 41
Beck-Engeser, Eilat, Wabl (CR59) 2011; 8
Frémond, Rodero, Jeremiah, Belot, Jeziorski, Duffy, Bessis, Cros, Rice, Charbit, Hulin, Khoudour, Caballero, Bodemer, Fabre, Berteloot, le Bourgeois, Reix, Walzer, Moshous, Blanche, Fischer, Bader-Meunier, Rieux-Laucat, Crow, Neven (CR52) 2016; 138
Rice, Newman, Dean, Patrick, Parmar, Flintoff, Robins, Harvey, Hollis, O’Hara, Herrick, Bowden, Perrino, Lindahl, Barnes, Crow (CR39) 2007; 80
Rice, Forte, Szynkiewicz, Chase, Aeby, Abdel-Hamid (CR12) 2013; 12
Lahouassa, Daddacha, Hofmann, Ayinde, Logue, Dragin (CR31) 2012; 13
Brehm, Liu, Sheikh, Marrero, Omoyinmi, Zhou, Montealegre, Biancotto, Reinhardt, Almeida de Jesus, Pelletier, Tsai, Remmers, Kardava, Hill, Kim, Lachmann, Megarbane, Chae, Brady, Castillo, Brown, Casano, Gao, Chapelle, Huang, Stone, Chen, Sotzny, Lee, Kastner, Torrelo, Zlotogorski, Moir, Gadina, McCoy, Wesley, Rother, Hildebrand, Brogan, Krüger, Aksentijevich, Goldbach-Mansky (CR47) 2015; 125
Namjou, Kothari, Kelly, Glenn, Ojwang, Adler, Alarcón-Riquelme, Gallant, Boackle, Criswell, Kimberly, Brown, Edberg, Stevens, Jacob, Tsao, Gilkeson, Kamen, Merrill, Petri, Goldman, Vila, Anaya, Niewold, Martin, Pons-Estel, Sabio, Callejas, Vyse, Bae, Perrino, Freedman, Scofield, Moser, Gaffney, James, Langefeld, Kaufman, Harley, Atkinson (CR66) 2011; 12
Stetson, Ko, Heidmann, Medzhitov (CR20) 2008; 134
Crow, Leitch, Hayward, Garner, Parmar, Griffith, Ali, Semple, Aicardi, Babul-Hirji, Baumann, Baxter, Bertini, Chandler, Chitayat, Cau, Déry, Fazzi, Goizet, King, Klepper, Lacombe, Lanzi, Lyall, Martínez-Frías, Mathieu, McKeown, Monier, Oade, Quarrell, Rittey, Rogers, Sanchis, Stephenson, Tacke, Till, Tolmie, Tomlin, Voit, Weschke, Woods, Lebon, Bonthron, Ponting, Jackson (CR14) 2006; 38
Achleitner, Kleefisch, Hennig, Peschke, Polikarpova, Oertel (CR63) 2017; 199
Reijns, Rabe, Rigby, Mill, Astell, Lettice (CR23) 2012; 149
Rice, Kasher, Forte, Mannion, Greenwood, Szynkiewicz (CR16) 2012; 44
Schlee, Hartmann (CR2) 2016; 16
Manthiram, Zhou, Aksentijevich, Kastner (CR1) 2017; 18
Kassiotis, Stoye (CR58) 2016; 16
CR67
CR64
Hiller, Achleitner, Glage, Naumann, Behrendt, Roers (CR24) 2012; 209
Mackenzie, Carroll, Lettice, Tarnauskaitė, Reddy, Dix, Revuelta, Abbondati, Rigby, Rabe, Kilanowski, Grimes, Fluteau, Devenney, Hill, Reijns, Jackson (CR28) 2016; 35
Goldstone, Ennis-Adeniran, Hedden, Groom, Rice, Christodoulou (CR30) 2011; 480
Assi, Verstovsek, Daver (CR49) 2017; 24
J Aicardi (743_CR7) 1984; 15
JL Sparks (743_CR25) 2012; 47
CA Thomas (743_CR60) 2017; 21
B Namjou (743_CR66) 2011; 12
MA Lee-Kirsch (743_CR65) 2007; 39
C Gunther (743_CR27) 2015; 125
EE Gray (743_CR22) 2015; 195
G Kassiotis (743_CR58) 2016; 16
YJ Crow (743_CR4) 2011; 1238
JC Ravenscroft (743_CR41) 2011; 155A
R Assi (743_CR49) 2017; 24
743_CR64
E Cuadrado (743_CR11) 2014; 74
GI Rice (743_CR12) 2013; 12
S Ahmad (743_CR62) 2018; 172
BJ Liddicoat (743_CR37) 2015; 349
M Schlee (743_CR2) 2016; 16
MA Lee-Kirsch (743_CR40) 2007; 85
DC Goldstone (743_CR30) 2011; 480
R Clifford (743_CR36) 2014; 123
743_CR67
Y Liu (743_CR46) 2012; 64
MA Lee-Kirsch (743_CR38) 2006; 79
KJ Mackenzie (743_CR28) 2016; 35
E Ballana (743_CR61) 2015; 23
V Tüngler (743_CR54) 2016; 75
JJ O’Shea (743_CR48) 2015; 66
V Pokatayev (743_CR29) 2016; 213
MA Lee-Kirsch (743_CR5) 2017; 68
J Seo (743_CR53) 2017; 139
R Furie (743_CR69) 2017; 69
AK Agarwal (743_CR45) 2010; 87
N Jeremiah (743_CR44) 2014; 124
MA Reijns (743_CR23) 2012; 149
GI Rice (743_CR17) 2014; 46
Y Liu (743_CR43) 2014; 371
K Peschke (743_CR71) 2016; 197
743_CR35
M Khamashta (743_CR68) 2016; 75
JS Smolen (743_CR51) 2017; 76
G Ramantani (743_CR10) 2011; 26
YG Yang (743_CR18) 2007; 131
C Wolf (743_CR19) 2016; 7
M-L Frémond (743_CR70) 2017; 69
LB Ivashkiv (743_CR3) 2014; 14
743_CR42
YJ Crow (743_CR14) 2006; 38
GI Rice (743_CR15) 2009; 41
A Ablasser (743_CR21) 2014; 192
DB Stetson (743_CR20) 2008; 134
V Tungler (743_CR32) 2013; 91
N Beloglazova (743_CR33) 2013; 288
M-L Frémond (743_CR52) 2016; 138
M Achleitner (743_CR63) 2017; 199
G Rice (743_CR39) 2007; 80
J Ryoo (743_CR34) 2014; 20
G Ramantani (743_CR9) 2010; 62
M Jagasia (743_CR50) 2018; 10
GI Rice (743_CR16) 2012; 44
N Yan (743_CR57) 2010; 11
H Lahouassa (743_CR31) 2012; 13
K Manthiram (743_CR1) 2017; 18
B Kind (743_CR26) 2014; 23
YJ Crow (743_CR13) 2006; 38
B Hiller (743_CR24) 2012; 209
YJ Crow (743_CR8) 2015; 167A
MP Rodero (743_CR6) 2017; 8
GB Beck-Engeser (743_CR59) 2011; 8
A Brehm (743_CR47) 2015; 125
743_CR55
743_CR56
References_xml – volume: 14
  start-page: 36
  year: 2014
  end-page: 49
  ident: CR3
  article-title: Regulation of type I interferon responses
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3581
– volume: 371
  start-page: 507
  year: 2014
  end-page: 518
  ident: CR43
  article-title: Activated STING in a vascular and pulmonary syndrome
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1312625
– volume: 66
  start-page: 311
  year: 2015
  end-page: 328
  ident: CR48
  article-title: The JAK-STAT pathway: impact on human disease and therapeutic intervention
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-051113-024537
– volume: 8
  start-page: 91
  year: 2011
  ident: CR59
  article-title: An autoimmune disease prevented by anti-retroviral drugs
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-8-91
– volume: 68
  start-page: 297
  year: 2017
  end-page: 315
  ident: CR5
  article-title: The type I interferonopathies
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-050715-104506
– volume: 13
  start-page: 223
  year: 2012
  end-page: 228
  ident: CR31
  article-title: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates
  publication-title: Nat Immunol
  doi: 10.1038/ni.2236
– volume: 16
  start-page: 566
  year: 2016
  end-page: 580
  ident: CR2
  article-title: Discriminating self from non-self in nucleic acid sensing
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2016.78
– volume: 76
  start-page: 960
  year: 2017
  end-page: 977
  ident: CR51
  article-title: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-210715
– volume: 125
  start-page: 4196
  year: 2015
  end-page: 4211
  ident: CR47
  article-title: Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production
  publication-title: J Clin Invest
  doi: 10.1172/JCI81260
– volume: 80
  start-page: 811
  year: 2007
  end-page: 815
  ident: CR39
  article-title: Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome
  publication-title: Am J Hum Genet
  doi: 10.1086/513443
– volume: 21
  start-page: 319
  year: 2017
  end-page: 331.e8
  ident: CR60
  article-title: Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2017.07.009
– volume: 139
  start-page: 1396
  year: 2017
  end-page: 1399.e12
  ident: CR53
  article-title: Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.10.030
– ident: CR35
– volume: 172
  start-page: 797
  year: 2018
  end-page: 810.e13
  ident: CR62
  article-title: Breaching self-tolerance to Alu duplex RNA underlies MDA5-mediated inflammation
  publication-title: Cell
  doi: 10.1016/j.cell.2017.12.016
– volume: 18
  start-page: 832
  year: 2017
  end-page: 842
  ident: CR1
  article-title: The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation
  publication-title: Nat Immunol
  doi: 10.1038/ni.3777
– ident: CR42
– volume: 288
  start-page: 8101
  year: 2013
  end-page: 8110
  ident: CR33
  article-title: Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.431148
– volume: 155A
  start-page: 235
  year: 2011
  end-page: 237
  ident: CR41
  article-title: Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus
  publication-title: Am J Med Genet A
  doi: 10.1002/ajmg.a.33778
– volume: 69
  start-page: 1495
  year: 2017
  end-page: 1501
  ident: CR70
  article-title: Brief report: blockade of TANK-binding kinase 1/IKKɛ inhibits mutant stimulator of interferon genes (STING)-mediated inflammatory responses in human peripheral blood mononuclear cells
  publication-title: Arthritis Rheumatol Hoboken NJ
  doi: 10.1002/art.40122
– volume: 8
  start-page: 2176
  year: 2017
  ident: CR6
  article-title: Type I interferon-mediated autoinflammation due to DNase II deficiency
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01932-3
– volume: 26
  start-page: 1425
  year: 2011
  end-page: 1428
  ident: CR10
  article-title: Aicardi-Goutieres syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations
  publication-title: J Child Neurol
  doi: 10.1177/0883073811408310
– volume: 85
  start-page: 531
  year: 2007
  end-page: 537
  ident: CR40
  article-title: A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus
  publication-title: J Mol Med
  doi: 10.1007/s00109-007-0199-9
– ident: CR67
– volume: 23
  start-page: 680
  year: 2015
  end-page: 692
  ident: CR61
  article-title: SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2015.08.002
– volume: 197
  start-page: 2157
  year: 2016
  end-page: 2166
  ident: CR71
  article-title: Loss of Trex1 in dendritic cells is sufficient to trigger systemic autoimmunity
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1600722
– volume: 167A
  start-page: 296
  year: 2015
  end-page: 312
  ident: CR8
  article-title: Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
  publication-title: Am J Med Genet A
  doi: 10.1002/ajmg.a.36887
– volume: 1238
  start-page: 91
  year: 2011
  end-page: 98
  ident: CR4
  article-title: Type I interferonopathies: a novel set of inborn errors of immunity
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2011.06220.x
– volume: 192
  start-page: 5993
  year: 2014
  end-page: 5997
  ident: CR21
  article-title: TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1400737
– volume: 125
  start-page: 413
  year: 2015
  end-page: 424
  ident: CR27
  article-title: Defective removal of ribonucleotides from DNA promotes systemic autoimmunity
  publication-title: J Clin Invest
  doi: 10.1172/JCI78001
– ident: CR64
– volume: 46
  start-page: 503
  year: 2014
  end-page: 509
  ident: CR17
  article-title: Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
  publication-title: Nat Genet
  doi: 10.1038/ng.2933
– volume: 199
  start-page: 2261
  year: 2017
  end-page: 2269
  ident: CR63
  article-title: Lack of Trex1 causes systemic autoimmunity despite the presence of antiretroviral drugs
  publication-title: J Immunol Baltim
  doi: 10.4049/jimmunol.1700714
– volume: 69
  start-page: 376
  year: 2017
  end-page: 386
  ident: CR69
  article-title: Anifrolumab, an anti-interferon-α receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus
  publication-title: Arthritis Rheumatol Hoboken NJ.
  doi: 10.1002/art.39962
– volume: 16
  start-page: 207
  year: 2016
  end-page: 219
  ident: CR58
  article-title: Immune responses to endogenous retroelements: taking the bad with the good
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri.2016.27
– volume: 75
  start-page: 1909
  year: 2016
  end-page: 1916
  ident: CR68
  article-title: Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2015-208562
– volume: 75
  year: 2016
  ident: CR54
  article-title: Response to: “JAK inhibition in STING-associated interferonopathy” by Crow et al
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-210565
– volume: 12
  start-page: 1159
  year: 2013
  end-page: 1169
  ident: CR12
  article-title: Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(13)70258-8
– volume: 138
  start-page: 1752
  year: 2016
  end-page: 1755
  ident: CR52
  article-title: Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.07.015
– volume: 7
  start-page: 11752
  year: 2016
  ident: CR19
  article-title: RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA
  publication-title: Nat Commun
  doi: 10.1038/ncomms11752
– volume: 38
  start-page: 917
  year: 2006
  end-page: 920
  ident: CR13
  article-title: Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus
  publication-title: Nat Genet
  doi: 10.1038/ng1845
– volume: 124
  start-page: 5516
  year: 2014
  end-page: 5520
  ident: CR44
  article-title: Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations
  publication-title: J Clin Invest
  doi: 10.1172/JCI79100
– volume: 11
  start-page: 1005
  year: 2010
  end-page: 1013
  ident: CR57
  article-title: The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1
  publication-title: Nat Immunol
  doi: 10.1038/ni.1941
– volume: 38
  start-page: 910
  year: 2006
  end-page: 916
  ident: CR14
  article-title: Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection
  publication-title: Nat Genet
  doi: 10.1038/ng1842
– volume: 87
  start-page: 866
  year: 2010
  end-page: 872
  ident: CR45
  article-title: PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2010.10.031
– volume: 24
  start-page: 115
  year: 2017
  end-page: 124
  ident: CR49
  article-title: “JAK-ing” up the treatment of primary myelofibrosis: building better combination strategies
  publication-title: Curr Opin Hematol
  doi: 10.1097/MOH.0000000000000320
– volume: 20
  start-page: 936
  year: 2014
  end-page: 941
  ident: CR34
  article-title: The ribonuclease activity of SAMHD1 is required for HIV-1 restriction
  publication-title: Nat Med
  doi: 10.1038/nm.3626
– volume: 41
  start-page: 829
  year: 2009
  end-page: 832
  ident: CR15
  article-title: Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response
  publication-title: Nat Genet
  doi: 10.1038/ng.373
– volume: 64
  start-page: 895
  year: 2012
  end-page: 907
  ident: CR46
  article-title: Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity
  publication-title: Arthritis Rheum
  doi: 10.1002/art.33368
– volume: 149
  start-page: 1008
  year: 2012
  end-page: 1022
  ident: CR23
  article-title: Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development
  publication-title: Cell
  doi: 10.1016/j.cell.2012.04.011
– volume: 47
  start-page: 980
  year: 2012
  end-page: 986
  ident: CR25
  article-title: RNase H2-initiated ribonucleotide excision repair
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.06.035
– volume: 131
  start-page: 873
  year: 2007
  end-page: 886
  ident: CR18
  article-title: Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease
  publication-title: Cell
  doi: 10.1016/j.cell.2007.10.017
– volume: 134
  start-page: 587
  year: 2008
  end-page: 598
  ident: CR20
  article-title: Trex1 prevents cell-intrinsic initiation of autoimmunity
  publication-title: Cell
  doi: 10.1016/j.cell.2008.06.032
– volume: 480
  start-page: 379
  year: 2011
  end-page: 382
  ident: CR30
  article-title: HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
  publication-title: Nature
  doi: 10.1038/nature10623
– volume: 79
  start-page: 731
  year: 2006
  end-page: 737
  ident: CR38
  article-title: Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p
  publication-title: Am J Hum Genet
  doi: 10.1086/507848
– volume: 44
  start-page: 1243
  year: 2012
  end-page: 1248
  ident: CR16
  article-title: Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature
  publication-title: Nat Genet
  doi: 10.1038/ng.2414
– volume: 10
  start-page: 391
  year: 2018
  end-page: 402
  ident: CR50
  article-title: Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials
  publication-title: Immunotherapy
  doi: 10.2217/imt-2017-0156
– ident: CR56
– volume: 39
  start-page: 1065
  year: 2007
  end-page: 1067
  ident: CR65
  article-title: Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
  publication-title: Nat Genet
  doi: 10.1038/ng2091
– volume: 91
  start-page: 759
  year: 2013
  end-page: 770
  ident: CR32
  article-title: Single-stranded nucleic acids promote SAMHD1 complex formation
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-013-0995-3
– volume: 209
  start-page: 1419
  year: 2012
  end-page: 1426
  ident: CR24
  article-title: Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity
  publication-title: J Exp Med
  doi: 10.1084/jem.20120876
– volume: 349
  start-page: 1115
  year: 2015
  end-page: 1120
  ident: CR37
  article-title: RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself
  publication-title: Science
  doi: 10.1126/science.aac7049
– volume: 35
  start-page: 831
  year: 2016
  end-page: 844
  ident: CR28
  article-title: Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response
  publication-title: EMBO J
  doi: 10.15252/embj.201593339
– volume: 123
  start-page: 1021
  year: 2014
  end-page: 1031
  ident: CR36
  article-title: SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
  publication-title: Blood
  doi: 10.1182/blood-2013-04-490847
– volume: 12
  start-page: 270
  year: 2011
  end-page: 279
  ident: CR66
  article-title: Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort
  publication-title: Genes Immun
  doi: 10.1038/gene.2010.73
– volume: 23
  start-page: 5950
  year: 2014
  end-page: 5960
  ident: CR26
  article-title: Altered spatio-temporal dynamics of RNase H2 complex assembly at replication and repair sites in Aicardi-Goutieres syndrome
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddu319
– volume: 195
  start-page: 1939
  year: 2015
  end-page: 1943
  ident: CR22
  article-title: Cutting edge: cGAS is required for lethal autoimmune disease in the Trex1-deficient mouse model of Aicardi-Goutieres syndrome
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1500969
– ident: CR55
– volume: 74
  start-page: 1931
  year: 2014
  end-page: 1939
  ident: CR11
  article-title: Aicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2014-205396
– volume: 15
  start-page: 49
  year: 1984
  end-page: 54
  ident: CR7
  article-title: A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis
  publication-title: Ann Neurol
  doi: 10.1002/ana.410150109
– volume: 213
  start-page: 329
  year: 2016
  end-page: 336
  ident: CR29
  article-title: RNase H2 catalytic core Aicardi-Goutières syndrome-related mutant invokes cGAS-STING innate immune-sensing pathway in mice
  publication-title: J Exp Med
  doi: 10.1084/jem.20151464
– volume: 62
  start-page: 1469
  year: 2010
  end-page: 1477
  ident: CR9
  article-title: Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutieres syndrome
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27367
– volume: 24
  start-page: 115
  year: 2017
  ident: 743_CR49
  publication-title: Curr Opin Hematol
  doi: 10.1097/MOH.0000000000000320
– volume: 134
  start-page: 587
  year: 2008
  ident: 743_CR20
  publication-title: Cell
  doi: 10.1016/j.cell.2008.06.032
– volume: 209
  start-page: 1419
  year: 2012
  ident: 743_CR24
  publication-title: J Exp Med
  doi: 10.1084/jem.20120876
– volume: 10
  start-page: 391
  year: 2018
  ident: 743_CR50
  publication-title: Immunotherapy
  doi: 10.2217/imt-2017-0156
– volume: 14
  start-page: 36
  year: 2014
  ident: 743_CR3
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3581
– volume: 1238
  start-page: 91
  year: 2011
  ident: 743_CR4
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2011.06220.x
– volume: 20
  start-page: 936
  year: 2014
  ident: 743_CR34
  publication-title: Nat Med
  doi: 10.1038/nm.3626
– volume: 76
  start-page: 960
  year: 2017
  ident: 743_CR51
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-210715
– volume: 35
  start-page: 831
  year: 2016
  ident: 743_CR28
  publication-title: EMBO J
  doi: 10.15252/embj.201593339
– ident: 743_CR42
  doi: 10.1136/annrheumdis-2016-209841
– volume: 125
  start-page: 4196
  year: 2015
  ident: 743_CR47
  publication-title: J Clin Invest
  doi: 10.1172/JCI81260
– volume: 44
  start-page: 1243
  year: 2012
  ident: 743_CR16
  publication-title: Nat Genet
  doi: 10.1038/ng.2414
– volume: 16
  start-page: 566
  year: 2016
  ident: 743_CR2
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2016.78
– volume: 125
  start-page: 413
  year: 2015
  ident: 743_CR27
  publication-title: J Clin Invest
  doi: 10.1172/JCI78001
– volume: 139
  start-page: 1396
  year: 2017
  ident: 743_CR53
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.10.030
– volume: 11
  start-page: 1005
  year: 2010
  ident: 743_CR57
  publication-title: Nat Immunol
  doi: 10.1038/ni.1941
– volume: 16
  start-page: 207
  year: 2016
  ident: 743_CR58
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri.2016.27
– volume: 23
  start-page: 680
  year: 2015
  ident: 743_CR61
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2015.08.002
– volume: 13
  start-page: 223
  year: 2012
  ident: 743_CR31
  publication-title: Nat Immunol
  doi: 10.1038/ni.2236
– volume: 7
  start-page: 11752
  year: 2016
  ident: 743_CR19
  publication-title: Nat Commun
  doi: 10.1038/ncomms11752
– volume: 172
  start-page: 797
  year: 2018
  ident: 743_CR62
  publication-title: Cell
  doi: 10.1016/j.cell.2017.12.016
– volume: 38
  start-page: 910
  year: 2006
  ident: 743_CR14
  publication-title: Nat Genet
  doi: 10.1038/ng1842
– volume: 149
  start-page: 1008
  year: 2012
  ident: 743_CR23
  publication-title: Cell
  doi: 10.1016/j.cell.2012.04.011
– volume: 47
  start-page: 980
  year: 2012
  ident: 743_CR25
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.06.035
– ident: 743_CR64
– volume: 80
  start-page: 811
  year: 2007
  ident: 743_CR39
  publication-title: Am J Hum Genet
  doi: 10.1086/513443
– volume: 124
  start-page: 5516
  year: 2014
  ident: 743_CR44
  publication-title: J Clin Invest
  doi: 10.1172/JCI79100
– volume: 74
  start-page: 1931
  year: 2014
  ident: 743_CR11
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2014-205396
– volume: 12
  start-page: 270
  year: 2011
  ident: 743_CR66
  publication-title: Genes Immun
  doi: 10.1038/gene.2010.73
– volume: 8
  start-page: 2176
  year: 2017
  ident: 743_CR6
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01932-3
– volume: 123
  start-page: 1021
  year: 2014
  ident: 743_CR36
  publication-title: Blood
  doi: 10.1182/blood-2013-04-490847
– volume: 69
  start-page: 1495
  year: 2017
  ident: 743_CR70
  publication-title: Arthritis Rheumatol Hoboken NJ
  doi: 10.1002/art.40122
– volume: 12
  start-page: 1159
  year: 2013
  ident: 743_CR12
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(13)70258-8
– ident: 743_CR35
  doi: 10.1136/annrheumdis-2013-204845
– ident: 743_CR56
  doi: 10.1002/cpt.936
– volume: 18
  start-page: 832
  year: 2017
  ident: 743_CR1
  publication-title: Nat Immunol
  doi: 10.1038/ni.3777
– volume: 62
  start-page: 1469
  year: 2010
  ident: 743_CR9
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27367
– volume: 79
  start-page: 731
  year: 2006
  ident: 743_CR38
  publication-title: Am J Hum Genet
  doi: 10.1086/507848
– volume: 288
  start-page: 8101
  year: 2013
  ident: 743_CR33
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.431148
– volume: 64
  start-page: 895
  year: 2012
  ident: 743_CR46
  publication-title: Arthritis Rheum
  doi: 10.1002/art.33368
– volume: 480
  start-page: 379
  year: 2011
  ident: 743_CR30
  publication-title: Nature
  doi: 10.1038/nature10623
– volume: 192
  start-page: 5993
  year: 2014
  ident: 743_CR21
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1400737
– volume: 75
  start-page: 1909
  year: 2016
  ident: 743_CR68
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2015-208562
– volume: 15
  start-page: 49
  year: 1984
  ident: 743_CR7
  publication-title: Ann Neurol
  doi: 10.1002/ana.410150109
– volume: 21
  start-page: 319
  year: 2017
  ident: 743_CR60
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2017.07.009
– volume: 91
  start-page: 759
  year: 2013
  ident: 743_CR32
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-013-0995-3
– volume: 167A
  start-page: 296
  year: 2015
  ident: 743_CR8
  publication-title: Am J Med Genet A
  doi: 10.1002/ajmg.a.36887
– volume: 38
  start-page: 917
  year: 2006
  ident: 743_CR13
  publication-title: Nat Genet
  doi: 10.1038/ng1845
– volume: 41
  start-page: 829
  year: 2009
  ident: 743_CR15
  publication-title: Nat Genet
  doi: 10.1038/ng.373
– volume: 195
  start-page: 1939
  year: 2015
  ident: 743_CR22
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1500969
– volume: 131
  start-page: 873
  year: 2007
  ident: 743_CR18
  publication-title: Cell
  doi: 10.1016/j.cell.2007.10.017
– volume: 8
  start-page: 91
  year: 2011
  ident: 743_CR59
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-8-91
– volume: 371
  start-page: 507
  year: 2014
  ident: 743_CR43
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1312625
– volume: 213
  start-page: 329
  year: 2016
  ident: 743_CR29
  publication-title: J Exp Med
  doi: 10.1084/jem.20151464
– volume: 39
  start-page: 1065
  year: 2007
  ident: 743_CR65
  publication-title: Nat Genet
  doi: 10.1038/ng2091
– volume: 66
  start-page: 311
  year: 2015
  ident: 743_CR48
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-051113-024537
– volume: 85
  start-page: 531
  year: 2007
  ident: 743_CR40
  publication-title: J Mol Med
  doi: 10.1007/s00109-007-0199-9
– volume: 87
  start-page: 866
  year: 2010
  ident: 743_CR45
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2010.10.031
– volume: 75
  year: 2016
  ident: 743_CR54
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-210565
– volume: 69
  start-page: 376
  year: 2017
  ident: 743_CR69
  publication-title: Arthritis Rheumatol Hoboken NJ.
  doi: 10.1002/art.39962
– volume: 138
  start-page: 1752
  year: 2016
  ident: 743_CR52
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.07.015
– ident: 743_CR55
  doi: 10.1172/JCI98814
– volume: 197
  start-page: 2157
  year: 2016
  ident: 743_CR71
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1600722
– ident: 743_CR67
  doi: 10.1002/art.39810
– volume: 46
  start-page: 503
  year: 2014
  ident: 743_CR17
  publication-title: Nat Genet
  doi: 10.1038/ng.2933
– volume: 26
  start-page: 1425
  year: 2011
  ident: 743_CR10
  publication-title: J Child Neurol
  doi: 10.1177/0883073811408310
– volume: 349
  start-page: 1115
  year: 2015
  ident: 743_CR37
  publication-title: Science
  doi: 10.1126/science.aac7049
– volume: 155A
  start-page: 235
  year: 2011
  ident: 743_CR41
  publication-title: Am J Med Genet A
  doi: 10.1002/ajmg.a.33778
– volume: 68
  start-page: 297
  year: 2017
  ident: 743_CR5
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-050715-104506
– volume: 23
  start-page: 5950
  year: 2014
  ident: 743_CR26
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddu319
– volume: 199
  start-page: 2261
  year: 2017
  ident: 743_CR63
  publication-title: J Immunol Baltim
  doi: 10.4049/jimmunol.1700714
SSID ssj0020083
Score 2.2688081
SecondaryResourceType review_article
Snippet Purpose of Review To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Summary Type I...
To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Type I interferonopathies represent a...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 32
SubjectTerms Medicine
Medicine & Public Health
Pediatric Rheumatology (S Ozen
Rheumatology
Section Editor
Topical Collection on Pediatric Rheumatology
Title Therapeutic Approaches to Type I Interferonopathies
URI https://link.springer.com/article/10.1007/s11926-018-0743-3
https://www.ncbi.nlm.nih.gov/pubmed/29679241
https://www.proquest.com/docview/2028959132
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1534-6307
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0020083
  issn: 1523-3774
  databaseCode: AFBBN
  dateStart: 19990601
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1534-6307
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0020083
  issn: 1523-3774
  databaseCode: AGYKE
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1534-6307
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020083
  issn: 1523-3774
  databaseCode: U2A
  dateStart: 19990601
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB3RVkJc2JewVEHiBErVOM52jFBLAZVTK5WTFS-5gBLUpBe-nnGWVlBA6iUnZ5LMeHkv43kGuNEiYsR2bMvF-dGiCi-xjHW6EME912oqXBcKj1-80ZQ-zdxZXcedN7vdm5RkOVOvit0QjGj2G1ilrqbTgo6r-UkbOtHD6_NgybM0rChlUgm2QnjTJDN_M_J9OVrDmGv50XLZGe7BpHnharfJW29R8J74_KHluOEX7cNuDUPNqOo3B7Cl0kPYHteJ9iNwJqu6LDOqdcdVbhaZqZmr-WiWvxITNc_SrDzVWOXHMB0OJvcjqz5fwRIOpYXFQ49LKWOfEJVIT2mt9zBQoS0Ix4lQ2gIxrfLdREoaCxK7gS9tWyYCFz63T6lzAu00S9UZmC5aCAOfUC5i6ggvDkLOEblwGXoSGY4B_cbNTNTi4_oMjHe2kk3WzmDoDKadwRwDbpe3fFTKG_81vm5ix3B86KRHnKpskTOie50bIuk24LQK6tIcCT0f-adtwF0TIFYP4fzvZ51v1PoCdkgZYR3oS2gX84W6QhxT8G7db7vQmpLoC04p5fQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB1BKwEX9qWsQeIEStU4znasUEtLl1MqlZMVL72AEtSkF76ecZZWUEDiktNkksyM7TcZzzPAnSYRI5ZtmQ7OjyZVeIlkpMuFCO65ZlPhulF4NHZ7E_o8daZlH3da7XavSpL5TL1qdkMworNf38x5Ne1NqFPL92kN6u2nl0FnmWdpWJHTpBKUQnhTFTN_UvJ1OVrDmGv10XzZ6e5BWL1wsdvktbnIeFN8fONy_OcX7cNuCUONdhE3B7Ch4kPYGpWF9iOww1VfltEuecdVamSJoTNXo2_kvxJnap7ESX6qsUqPYdLthI89szxfwRQ2pZnJA5dLKSOPEDWTrtJc74GvAksQjhOhtARiWuU5MylpJEjk-J60LDkTuPA5LUrtE6jFSazOwHBQQ-B7hHIRUVu4kR9wjsiFy8CVmOE0oFWZmYmSfFyfgfHGVrTJ2hgMjcG0MZjdgPvlLe8F88ZfwreV7xiOD130iGKVLFJGdNQ5ASbdDTgtnLpURwLXw_zTasBD5SBWDuH092ed_0v6BrZ74WjIhv3x4AJ2SO5t7fRLqGXzhbpCTJPx6zKGPwHdZ-f8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB60QvEivo3PCJ6UULPZPPZY1NKqLR5a6G3ZV06SlCb9_86mSYtUBS85bSYwO9n5vkzmG4A7KyJG_MD3QjwfPWrwIrSw5UIE99KqqUjbKDwcRf0JfZ2G03rOadH87d6UJJc9DValKSs7M5121o1vCEwsE068SmMz2IYdiqnasq8J6a4YlwUYlWAqwTUIdJqy5k8mviemDbS5USmtElBvH_Zq5Oh2l1t9AFsmO4T2sK6NH0EwXrdSud1aKtwUbpm7lmy6A7f6-peaeZ7l1SBiUxzDpPcyfup79UgETwWUlp5kkdRai5gQk-rIWHl2lhjmKyLx7NK-Qhhq4jDVmgpFRJjE2vd1qjBXhY-UBifQyvLMnIEbogWWxIRKJWigIpEwKRFsSM0ijaTEgcfGH1zVeuF2bMUnXysdWxdydCG3LuSBA_erW2ZLsYy_Ft82TuYY0rZOITKTLwpObKCEDHmyA6dL76_MERbFSBl9Bx6a7eD1W1f8_qzzf62-gfbHc4-_D0ZvF7BLqhCxkXIJrXK-MFeIQkp5XUXaF2dsz3Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Therapeutic+Approaches+to+Type+I+Interferonopathies&rft.jtitle=Current+rheumatology+reports&rft.au=Bienias%2C+Marc&rft.au=Br%C3%BCck%2C+Normi&rft.au=Griep%2C+Constanze&rft.au=Wolf%2C+Christine&rft.date=2018-06-01&rft.eissn=1534-6307&rft.volume=20&rft.issue=6&rft.spage=32&rft_id=info:doi/10.1007%2Fs11926-018-0743-3&rft_id=info%3Apmid%2F29679241&rft.externalDocID=29679241
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1523-3774&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1523-3774&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1523-3774&client=summon